Biotechnology · Healthcare
Head of Investor Relations
Head of Investor Relations
Pelthos Therapeutics Inc. (PTHS)Equibles does not estimate personal net worth.
Get an email with a short summary when Pelthos Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get PTHS alertsMike Moyer is recorded as Head of Investor Relations at Pelthos Therapeutics Inc. (PTHS). Mike Moyer has spoken on 2 earnings calls across 1 company, most recently for Pelthos Therapeutics Inc. on August 13, 2026. Pelthos Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Pelthos Therapeutics Inc. includes Christian Kopfli (CEO), Francis Knuettel II (CEO, CFO and Chief Accounting Officer), Scott Plesha (CEO and Board Member) and 7 others.
“Good morning, everyone, and welcome to Peltos Therapeutics' 2026 Second Quarter Financial Results Conference Call. Peltos issued a press release today announcing its financial results for the quarter ended June 30, 2026.”
“Good morning, everyone, and welcome to the Peltos Therapeutics 2020-26 First Quarter Financial Results Conference Call. Peltos issued a press release today announcing its financial results for the quarter ended March 31, 2026.”
Biotechnology · Healthcare
Head of Investor Relations